Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen
Authors:
- Frank OberpenningFOFrank Oberpenning
- Burkhard BrandtBurkhard Brandt
- Christian ZechelCZChristian Zechel
- Wolfgang BrandauWBWolfgang Brandau
- Lothar HertleLHLothar Hertle
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Discordance of assay methods creates pitfalls for the interpretation of prostate-specific antigen valuesThe Prostate, 1996
- Methodological and clinical comparison of the acs prostate-specific antigen assay and the tandem-e prostate-specific antigen assay in prostate cancerUrology, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994
- Cost Analyses of Prostate Cancer Screening: Frameworks For DiscussionJournal of Urology, 1994
- Comparability of the tandem-R andIMx assays for the measurement of serum prostate-specific antigenUrology, 1994
- Standardization of immunoassays for prostate-specific antigen. A problem of prostate-specific antigen complexation or a problem of assay design?Cancer, 1993
- Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate CancerJournal of Urology, 1993
- Prostate Cancer in Nonurological Patients with Normal Prostates on Digital Rectal ExaminationJournal of Urology, 1992
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990
- Prostate-specific antigen—comparative clinical appreciation of a serodiagnostic measure after 8 years of experienceWorld Journal of Urology, 1989